-
BioScrip sales increase, profits decrease in Q3
ELMSFORD, N.Y. — Specialty pharmacy provider BioScrip reported $454 million in sales and $500,000 in profits in third quarter 2011, according to an earnings statement released Tuesday.
The sales figure represented a 2.9% increase over third quarter 2010's $441.2 million, while the profits compared with profits of $2 million during the same period a year ago.